Dr. Valentina R. Bradley Kalbaugh, MD

Dr. Bradley Kalbaugh practices at Ocala Family Medical Center - Outpatient Therapy in Ocala, Florida.

Dr. Bradley Kalbaugh's NPI, 1902898083, was assigned on August 16, 2005. Dr. Bradley Kalbaugh graduated from Harvard Medical School in 1998. Dr. Bradley Kalbaugh holds Florida license ME94814.

Dr. Bradley Kalbaugh's primary practice is Ocala Family Medical Center - Outpatient Therapy, at 2230 Sw 19th Avenue Rd, Ocala, FL 34471. The practice phone is (352) 237-4133.

Dr. Bradley Kalbaugh's primary practice is Ocala Family Medical Center - Outpatient Therapy in Ocala, Florida. The medical group on file is Ocala Family Medical Center. Dmand AI also links Dr. Bradley Kalbaugh to 1 more group practice or clinic, named with a free account. Dr. Bradley Kalbaugh's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bradley Kalbaugh practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Bradley Kalbaugh's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Bradley Kalbaugh is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bradley Kalbaugh's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Bradley Kalbaugh treats.

CMS data shows 5,077 Medicare services from Dr. Bradley Kalbaugh across 24 procedure codes in 2024, for 1,072 Medicare patients. Medicare paid $294,331 for them. Every service was in an office.

CMS counts 1,072 Medicare patients who saw Dr. Bradley Kalbaugh in 2024. The largest group is 65 to 74, with 598 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bradley Kalbaugh's median patient age at 66, with 56% women.

In 2024, Dr. Bradley Kalbaugh wrote 950 Medicare Part D claims for 414 patients. 93% of them were for generic drugs. CMS names the drug for 781 of them, across 18 drugs with 11 or more claims each, at $518,288 in total drug cost. In 2023, CMS named 676 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Bradley Kalbaugh for performance year 2024, reported as part of a group. Dr. Bradley Kalbaugh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 921 procedures of removal of skin lesions by Dr. Bradley Kalbaugh, more than 92% of the clinicians it reports for that procedure.

CMS Open Payments shows 175 general payments to Dr. Bradley Kalbaugh from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Sun Pharmaceutical Industries Inc. paid the most, $620.

Dmand AI lists 4 awards for Dr. Bradley Kalbaugh, most recently ASDS Fellow in 2013.

Dr. Bradley Kalbaugh graduated from Harvard Medical School in 1998. Dr. Bradley Kalbaugh is a member of AAD and ASDS.

Dr. Bradley Kalbaugh is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.